openPR Logo
Press release

Companion Diagnostics Market 2018 Global Trend, Segmentation and Opportunities Forecast To 2023

06-08-2018 08:42 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Market Research Future

/ PR Agency: Market Research Future
Global Companion Diagnostics Market By Application, is projected to grow at a CAGR of 15.4% and is expected to reach US$ 12,647.5 million by 2023. In Global Companion Diagnostics Market By Application, Cancer accounted for the largest market share in 2016.

Globally, Companion Diagnostics market is dominated by North America region. The global Companion diagnostics market comprises of application such as cancer, infectious diseases, cardiovascular diseases, CNS disorders, and others. Cancer captures maximum market share. However, infectious diseases segment is developing and it is expected to grow at the highest growth rate during the forecasted period of 2017 to 2023.

Companion Diagnostics is the as a bio-analytical method designed for the assessment of the patient to check whether patient responds to a specific medical treatment or not. Companion diagnostics are used to determine which patients are benefited from a certain type of medication or which therapies are best suited for the patients with certain medical conditions. Companion diagnostics involves tests and devices or tools which provide information about the safe and effective use of the specific therapeutic product. It not only provides information about the efficacy of the drugs but also the side effects that are associated with the drug. To control the rising cost of the drug discovery and development for the deadly and chronic diseases, the need for companion diagnostics is increasing; and with the increasing demand for the companion diagnostic tools and techniques, the global market for the companion diagnostics is growing.

FIGURE 1 Global Companion Diagnostics Market By Application, 2016 & 2023 (%)
Global Companion Diagnostics Market By Application from 2017 to 2023 -Report image 00
Global Companion Diagnostics Market By Application statistical report published by Market Research future contains a brief overview of market of various application of companion diagnostics. The report analyzed the Global Companion Diagnostics Market By Application and present systematic data of market share on the basis of segments and countries, and its growth rate for 2014 to 2017, along with forecast till 2023.
Market Research future through this report aims to provide understanding of the Global Companion Diagnostics Market By Application on the basis of segments & countries, and also assists identification of ongoing trends along with anticipated growth during the forecasted period. For this report, extensive primary research was conducted to gain a deeper insight of the market performance. Various industry experts and Key Opinion Leaders (KOLs) were contacted and interviewed to get an idea of Global Companion Diagnostics Market By Application.

List of Tables
TABLE 1 GLOBAL COMPANION DIAGNOSTICS MARKET, BY APPLICATION, 2014-2023 (USD MILLION) 9
TABLE 2 GLOBAL COMPANION DIAGNOSTICS MARKET FOR CANCER, BY REGION, 2014-2023 (USD MILLION) 10
TABLE 3 GLOBAL COMPANION DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY REGION, 2014-2023 (USD MILLION) 11
TABLE 4 GLOBAL COMPANION DIAGNOSTICS MARKET FOR CARDIOVASCULAR DISEASES, BY REGION, 2014-2023 (USD MILLION) 12
TABLE 5 GLOBAL COMPANION DIAGNOSTICS MARKET FOR CNS DISORDERS, BY REGION, 2014-2023 (USD MILLION) 13
TABLE 6 AMERICA COMPANION DIAGNOSTICS MARKET, BY APPLICATION, 2014-2023 (USD MILLION) 13
TABLE 8 US COMPANION DIAGNOSTICS MARKET, BY APPLICATION, 2014-2023 (USD MILLION) 14
TABLE 9 CANADA COMPANION DIAGNOSTICS MARKET, BY APPLICATION, 2014-2023 (USD MILLION) 14
TABLE 11 SOUTH AMERICA COMPANION DIAGNOSTICS MARKET, BY APPLICATION, 2014-2023 (USD MILLION) 15
TABLE 12 EUROPE COMPANION DIAGNOSTICS MARKET, BY APPLICATION, 2014-2023 (USD MILLION) 15
TABLE 14 GERMANY COMPANION DIAGNOSTICS MARKET, BY APPLICATION, 2014-2023 (USD MILLION) 16
TABLE 15 FRANCE COMPANION DIAGNOSTICS MARKET, BY APPLICATION, 2014-2023 (USD MILLION) 16
TABLE 17 U.K. COMPANION DIAGNOSTICS MARKET, BY APPLICATION, 2014-2023 (USD MILLION) 17
TABLE 18 ITALY COMPANION DIAGNOSTICS MARKET, BY APPLICATION, 2014-2023 (USD MILLION) 17
TABLE 20 SPAIN COMPANION DIAGNOSTICS MARKET, BY APPLICATION, 2014-2023 (USD MILLION) 18
TABLE 21 REST OF WESTERN EUROPE COMPANION DIAGNOSTICS MARKET, BY APPLICATION, 2014-2023 (USD MILLION) 18
TABLE 23 EASTERN EUROPE COMPANION DIAGNOSTICS MARKET, BY APPLICATION, 2014-2023 (USD MILLION) 19
TABLE 24 ASIA-PACIFIC COMPANION DIAGNOSTICS MARKET, BY APPLICATION, 2014-2023 (USD MILLION) 19
TABLE 26 JAPAN COMPANION DIAGNOSTICS MARKET, BY APPLICATION, 2014-2023 (USD MILLION) 20
TABLE 27 CHINA COMPANION DIAGNOSTICS MARKET, BY APPLICATION, 2014-2023 (USD MILLION) 20
TABLE 29 INDIA COMPANION DIAGNOSTICS MARKET, BY APPLICATION, 2014-2023 (USD MILLION) 21
TABLE 30 REPUBLIC OF KOREA COMPANION DIAGNOSTICS MARKET, BY APPLICATION, 2014-2023 (USD MILLION) 21
TABLE 32 REST OF ASIA-PACIFIC COMPANION DIAGNOSTICS MARKET, BY APPLICATION, 2014-2023 (USD MILLION) 22
TABLE 33 MIDDLE EAST & AFRICA COMPANION DIAGNOSTICS MARKET, BY APPLICATION, 2014-2023 (USD MILLION) 22
TABLE 35 MIDDLE EAST COMPANION DIAGNOSTICS MARKET, BY APPLICATION, 2014-2023 (USD MILLION) 23
TABLE 36 AFRICA COMPANION DIAGNOSTICS MARKET, BY APPLICATION, 2014-2023 (USD MILLION) 23

List of Figures
FIGURE 1 GLOBAL COMPANION DIAGNOSTICS MARKET, BY APPLICATION, 2016 & 2023 (USD MILLION) 8

Enquire now: https://www.marketresearchfuture.com/statistical-reports/enquiry/3531

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Companion Diagnostics Market 2018 Global Trend, Segmentation and Opportunities Forecast To 2023 here

News-ID: 1075221 • Views:

More Releases from Market Research Future

Americas Recycled Plastics Market: Opportunities For Higher Growth| Delta Plastics, UltrePET, Biocirculo
Americas Recycled Plastics Market: Opportunities For Higher Growth| Delta Plasti …
Global Americas Recycled Plastics Market Report from Market Research Forecast highlights deep analysis on market characteristics, sizing, estimates and growth by segmentation, regional breakdowns & country along with competitive landscape, player's market shares, and strategies that are key in the market. The exploration provides a 360° view and insights, highlighting major outcomes of the industry. These insights help the business decision-makers to formulate better business plans and make informed decisions
Hydrofluoric Acid Market (CAGR) of 4%, Innovation Imperative Future Proofing Your Business with Market Size
Hydrofluoric Acid Market (CAGR) of 4%, Innovation Imperative Future Proofing You …
Hydrofluoric acid (HF) is a crucial chemical compound with a wide range of applications across various industries. Despite its hazardous nature, it plays an essential role in manufacturing processes, especially in the production of fluorine compounds. The global hydrofluoric acid market has been witnessing steady growth, driven by demand from end-user industries such as oil refining, pharmaceuticals, and electronics. The Hydrodesulfurization Catalysts Market is projected to register a CAGR of over
Palm Methyl Ester Derivative Market Size Projected to Grow at 5.92% CAGR, Reaching USD 2.4 billion by 2030
Palm Methyl Ester Derivative Market Size Projected to Grow at 5.92% CAGR, Reachi …
In recent years, the global market for palm methyl ester derivatives has witnessed significant growth, driven by various factors including environmental concerns, technological advancements, and the increasing demand for sustainable alternatives in various industries. Palm methyl ester derivatives, derived from palm oil, have emerged as versatile ingredients with applications spanning across sectors such as cosmetics, pharmaceuticals, lubricants, and more. The Palm Methyl Ester Derivative Market Size was valued at USD 1.5
Asia-Pacific Ceramic Tiles Market to Register Highest CAGR Growth of 7.50% by 2032: Analysis by Segmentation, Competitors Analysis
Asia-Pacific Ceramic Tiles Market to Register Highest CAGR Growth of 7.50% by 20 …
The Asia-Pacific ceramic tiles market has been witnessing robust growth, driven by various factors such as increasing investments in residential and commercial construction, renovation activities, and the growing preference for aesthetically pleasing and durable flooring solutions. Countries like China, India, Japan, and South Korea have been leading the market growth, supported by strong manufacturing capabilities, technological advancements, and evolving consumer preferences. Asia-Pacific Ceramic Tiles Market Size was valued at USD 141.2

All 5 Releases


More Releases for COMPANION

Companion Animal Drugs - Key Market Statistics
Companion animals are pets kept primarily for company, entertainment, and safety. Owners of companion animals consider them to be family, friends, and confidants. Dogs, cats, birds, rabbits, horses, goats, gerbils, rats, mice, and amphibians, others are considered as companion animals. Read Report Overview - https://www.transparencymarketresearch.com/companion-animal-specialty-drugs-market.html According to the American Society for the Prevention of Cruelty to Animals (ASPCA) defines companion animal to be domesticated or domestically-bred whose emotional, physical, social, and behavioral
Companion Animal Vaccine – Improving The Health Of Companion Animals In A Cost …
The companion animal vaccines market is expected to witness significant growth during the forecast period due to launch of vaccines for companion animals. For instance, in December 2017, Zoetis Inc. announced the launch of Vanguard CIV H3N2/H3N8, the latest vaccine in the company’s canine influenza virus (CIV) portfolio. The new bivalent vaccine helps protect dogs against the two strains of the virus known to be circulating in the U.S. Moreover, the
Companion Diagnostics Market - Easing of Regulatory Policies to Drive Global Dem …
Companion diagnostics include two types of tests namely tests which are developed along with target drugs and the other developed after the commercialization of drugs. Companion diagnostics combined with targeted therapeutics are being seen as a major breakthrough in the personalized medicine field. Companies operating in the companion diagnostics market are seeking an effective growth strategy in the development of this concept drug-diagnostic interaction as the healthcare sector is shifting
Global Companion Diagnostics Market
The Global Companion Diagnostics (CDx) Market was valued at US$ 1,614.5 million in 2015 and is projected to expand at a CAGR of 12.0% during the forecast period (2016–2024), as highlighted in a new report published by Coherent Market Insights. Development of multiple biomarkers and targeted drug therapy is boosting research and development collaboration among the industry players. This is expected to improve the time to market for companion diagnostic (CDx) test
Global Companion Diagnostics – Growth Companion for Personalized Medicine
Companion Diagnostics: Growth Companion for Personalized Medicine Personalized medicine is the new segment in discussion among healthcare experts around the globe. Also, encouragement from the regulatory bodies such as the FDA and EMEA in erms of providing a defined structure for companion diagnostic development is driving research activities in personalized medicine. Diagnosis at molecular level for each individual is of prime importance to identify the target biomarker before deciding the therapy.
Companion diagnostics Market: Companion diagnostic are used to determine patient …
The few companion diagnostics are already available in the market for specific types of cancer and many are already under clinical development. Companion diagnostics test depends on finding a specific biomarker in the patient and hence biomarker presence or absence determines whether or not the patient will respond to the treatment. This test require a biopsied tissue to access the expression of biomarker protein or mutant or aberrant genes. Companion